NEUROCHEM INC.
News published by NEUROCHEM INC. officials updates activities
Published in Medicine and Law Weekly, June 1st, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at NEUROCHEM INC..
Report 1: Neurochem (International) Limited (Neurochem), a wholly owned subsidiary of Neurochem Inc. (NASDAQ: NRMX; TSX: NRM), announces that it received notification from the United States Food and Drug Administration (FDA) that the action date for FDA's review of the New Drug Application (NDA) for eprodisate (KIACTA(TM)) for the treatment of Amyloid A (AA) amyloidosis, has been extended to July 16, 2007. Previously, the action date under the Prescription Drug User Fee...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
More Articles from Medicine and Law Weekly
- Bipolar Disorders Therapy
Research on bipolar disorders therapy detailed by scientists at School of Medicine, Department of Psychiatry - Clinical Trial Research
Scientists at Monash University report research in clinical trial research - Life Sciences
Data on life sciences described by investigators at University of Kentucky, Center on Drug and Alcohol Research - Life Sciences
Data on life sciences discussed by researchers at University of Medicine - Life Sciences
New life sciences research has been reported by scientists at Centers for Disease Control and Prevention - Life Sciences
Reports on life sciences findings from Alcohol Research Group provide new insights - More from this issue of Medicine and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
